--- title: "300181.SZ (300181.SZ) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/300181.SZ/news.md" symbol: "300181.SZ" name: "300181.SZ" parent: "https://longbridge.com/en/quote/300181.SZ.md" datetime: "2026-05-21T06:25:37.477Z" locales: - [en](https://longbridge.com/en/quote/300181.SZ/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/300181.SZ/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/300181.SZ/news.md) --- # 300181.SZ (300181.SZ) — Related News ### [Jolly: The total amount of funds raised from the issuance of convertible corporate bonds has been reduced to 1.523 billion yuan](https://longbridge.com/en/news/286388586.md) *2026-05-14T09:09:50.000Z* > Jolly announced that the company has decided to reduce the total amount of funds raised from the issuance of convertible ### [Investors greatly disappointed? Behind the dividend cut, Jolly's long-term layout has already taken shape](https://longbridge.com/en/news/286208914.md) *2026-05-13T06:29:03.000Z* > Jolly announced a reduction in its 2025 dividend from 6 yuan per 10 shares to 3.5 yuan per 10 shares against the backdro ### [Jolly released its first-quarter performance, with a net profit attributable to the parent company of 200 million yuan, an increase of 10.18%](https://longbridge.com/en/news/284107285.md) *2026-04-26T09:56:05.000Z* > Jolly released its first quarter report for 2026, with operating revenue of 898 million yuan, a year-on-year increase of ### [Jolly: Revenue of 3.041 billion yuan in 2025, net profit increased by 24.45% year-on-year](https://longbridge.com/en/news/284103081.md) *2026-04-26T07:48:18.000Z* > Jolly expects a revenue of 3.041 billion yuan in 2025, a year-on-year increase of 17.96%; net profit of 632 million yuan ### [Jolly: Shenling Granules have received the Notice of Approval for Clinical Trials](https://longbridge.com/en/news/282315037.md) *2026-04-10T08:50:28.000Z* > Jolly announced that its self-developed traditional Chinese medicine new drug Shenling Granules has received the clinica ### [Jolly obtained the drug registration certificate for Pidotimod Granules](https://longbridge.com/en/news/279222474.md) *2026-03-16T07:57:02.000Z* > Jolly announced that the company has obtained the "Drug Registration Certificate" for Polycarbophil Calcium Granules iss ### [In the first instance of the patent rights dispute case, HUADONG MEDICINE lost and has once again sued Jolly](https://longbridge.com/en/news/277272434.md) *2026-02-28T03:45:11.000Z* > HUADONG MEDICINE's wholly-owned subsidiary, Sino-American HUADONG, has sued Jolly and its holding subsidiary, ZhuFeng Ph ### [Jolly's core product strategy upgrade reveals a path for future scaled growth](https://longbridge.com/en/news/274411574.md) *2026-02-01T07:42:08.000Z* > On January 30th, Jolly (300181) held its 30th anniversary celebration and the launch event for the new Wuling brand. Cor